Given the pivotal role of LAMP2 in lysosomal stability, targeting LAMP2 could be a strategy to destabilize lysosomes of cancer cells and potentiate the efficacy of lysosomotropic agents, which accumulates into lysosomes and damage them, resulting in LMP and activation of cell death13. Here, PDLIM7 is linked to cancer.